How should morning function in rheumatoid arthritis be assessed? Bibliographic study of current assessment

被引:11
作者
Cutolo, M. [1 ,2 ]
机构
[1] Univ Genoa, Res Lab, Dept Internal Med, I-16132 Genoa, Italy
[2] Univ Genoa, Acad Unit Clin Rheumatol, Dept Internal Med, I-16132 Genoa, Italy
关键词
HEALTH-ASSESSMENT QUESTIONNAIRE; PATIENT-REPORTED OUTCOMES; ACR REMISSION CRITERIA; NECROSIS-FACTOR-ALPHA; DISEASE-ACTIVITY; DOUBLE-BLIND; UNDIFFERENTIATED ARTHRITIS; CIRCADIAN-RHYTHMS; MODIFIED-RELEASE; PREDICTION RULE;
D O I
10.3109/03009742.2011.566436
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with rheumatoid arthritis (RA), symptoms of joint stiffness and pain may be most severe in the morning, resulting in impaired ability to carry out normal morning functions. Although morning stiffness was included in the criteria for classification and remission of RA, defined by the American College of Rheumatology (ACR) in 1987, the approach to assessment of this circadian symptom has not been standardized, and other circadian aspects of the disease (i.e. pain, functional ability) were not included. A bibliographic study of papers published in English in the period January 2007 to January 2010 and reporting morning stiffness, pain or function was undertaken to investigate methods of assessing circadian aspects of RA. A total of 73 studies were identified using Medline, including 62 clinical trials. Full papers were obtained for 52 reports of clinical studies (84%), most of which (44/52, 85%) assessed duration of morning stiffness. Only two studies (4%) specified that severity of morning stiffness was assessed, only three (6%) assessed pain in the morning, and none assessed morning functional ability. These findings suggest the need for consistent reporting of a measure to reflect the impaired morning function, arising from joint stiffness and pain that is commonly experienced by patients.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 70 条
  • [11] Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial
    Buttgereit, Frank
    Doering, Gisela
    Schaeffler, Achim
    Witte, Stephan
    Sierakowski, Stanislaw
    Gromnica-Ihle, Erika
    Jeka, Slawomir
    Krueger, Klaus
    Szechinski, Jacek
    Alten, Rieke
    [J]. LANCET, 2008, 371 (9608) : 205 - 214
  • [12] Conway R, 2010, ANN RHEUM DIS S3, V69, P473
  • [13] Circulating E-selectin and tumor necrosis factor-α in extraarticular involvement and joint disease activity in rheumatoid arthritis
    Corona-Sanchez, Esther G.
    Gonzalez-Lopez, Laura
    Munoz-Valle, Jose F.
    Vazquez-Del Mercado, Monica
    Lopez-Olivo, Maria A.
    Aguilar-Chavez, Erika A.
    Salazar-Paramo, Mario
    Loaiza-Cardenas, Carlos
    Oregon-Romero, Edith
    Navarro-Hernandez, Rosa E.
    Gamez-Nava, Jorge I.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2009, 29 (03) : 281 - 286
  • [14] Cutolo M, 2010, ANN RHEUM DIS S3, V69, P676
  • [15] Circadian rhythms in arthritis: Hormonal effects on the immune/inflammatory reaction
    Cutolo, Maurizio
    Straub, Rainer H.
    [J]. AUTOIMMUNITY REVIEWS, 2008, 7 (03) : 223 - 228
  • [16] Impact of impaired morning function on the lives and well-being of patients with rheumatoid arthritis
    da Silva, J. A. P.
    Phillips, S.
    Buttgereit, F.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2011, 40 : 6 - 11
  • [17] Development of a scoring system for assessment of outcome of early undifferentiated inflammatory synovitis
    El Miedany, Yasser
    Youssef, Sally
    Melianna, Annie N.
    El Gaafary, Maha
    [J]. JOINT BONE SPINE, 2008, 75 (02) : 155 - 162
  • [18] Association of Body Composition With Disability in Rheumatoid Arthritis: Impact of Appendicular Fat and Lean Tissue Mass
    Giles, Jon T.
    Bartlett, Susan J.
    Andersen, Ross E.
    Fontaine, Kevin R.
    Bathon, Joan M.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (10): : 1407 - 1415
  • [19] HAZES JMW, 1993, J RHEUMATOL, V20, P1138
  • [20] B-cell depletion in patients with rheumatoid arthritis refractant to multiple TNF blockers and the interleukin 1 receptor-antagonist anakinra - Good responses in an extreme negative selection
    Henes, J. C.
    Richter, C.
    Kanz, L.
    Koetter, I.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2007, 28 (01) : 33 - 37